Announcements Trials

Browse Landscape

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 10 Breast Neoplasms 5 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Ovarian Neoplasms 2 Neoplasms, Unknown Primary 2 Lung Neoplasms 2 Carcinoma 2 Urologic Neoplasms 1 Urogenital Neoplasms 1 Unresectable Stage III NSCLC 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Penile Neoplasms 1 Pathologic Complete Response 1 Ovarian Diseases 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Male Urogenital Diseases 1 Genital Neoplasms, Female 1 Genital Diseases, Female 1 First-line Advanced NSCLC Patients 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Endocrine System Diseases 1 Carcinoma, Ovarian Epithelial 1

Interventions

Cisplatin 88 Fluorouracil 71 Paclitaxel 69 Radiotherapy 63 Oxaliplatin 55 Irinotecan 37 Docetaxel 36 Carboplatin 36 Leucovorin 34 Capecitabine 28 Radiation 25 Surgical Procedures, Operative 22 Drug Therapy 19 pembrolizumab 18 Cetuximab 15 Bevacizumab 15 Nivolumab 14 tislelizumab 12 camrelizumab 11 Neoadjuvant Therapy 11 Esophagectomy 11 Chemoradiotherapy 11 S 1 (combination) 10 Albumin-Bound Paclitaxel 10 nimotuzumab 9 Trastuzumab 9 durvalumab 8 Radiotherapy, Intensity-Modulated 8 Gefitinib 7 Epirubicin 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Esophageal Neoplasms × CP protocol × Clear all

NCT02924909 2018-03-20

QUIMERA

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡